Equities

Biokarpet Industrial and Commercial Enterprises SA

BIOKA:ATH

Biokarpet Industrial and Commercial Enterprises SA

Actions
  • Price (EUR)1.74
  • Today's Change0.02 / 1.16%
  • Shares traded12.51k
  • 1 Year change-35.56%
  • Beta0.8404
Data delayed at least 20 minutes, as of Nov 21 2024 15:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Biokarpet Industrial and Commercial Enterprises SA's revenues fell -9.18% from 231.22m to 209.99m. 8.99m to 5.49m, a -38.94% decrease.
Gross margin16.06%
Net profit margin1.73%
Operating margin5.75%
Return on assets1.63%
Return on equity7.04%
Return on investment2.32%
More ▼

Cash flow in EURView more

In 2023, Biokarpet Industrial and Commercial Enterprises SA increased its cash reserves by 104.18%, or 3.83m. The company earned 11.99m from its operations for a Cash Flow Margin of 5.71%. In addition the company generated 3.80m cash from financing while 11.96m was spent on investing.
Cash flow per share0.4114
Price/Cash flow per share4.18
Book value per share2.03
Tangible book value per share2.02
More ▼

Balance sheet in EURView more

Biokarpet Industrial and Commercial Enterprises SA has a Debt to Total Capital ratio of 68.87%, a lower figure than the previous year's 213.34%.
Current ratio1.73
Quick ratio1.14
Total debt/total equity2.25
Total debt/total capital0.6887
More ▼

Growth rates in EUR

Year on year, growth in earnings per share excluding extraordinary items dropped -38.94%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
EPS growth(5 years)100.20
EPS (TTM) vs
TTM 1 year ago
-20.38
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.